Tetracycline administration restores osteoblast structure and function during experimental diabetes.
about
Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice.P2X7R-Panx1 Complex Impairs Bone Mechanosignaling under High Glucose Levels Associated with Type-1 DiabetesIs insulin an anabolic agent in bone? Dissecting the diabetic bone for clues.Review: The diabetic bone: a cellular and molecular perspective.Effects of the anti-androgen finasteride on 5alpha-reductase activity in human gingival fibroblasts in response to minocycline.A new perspective on mechanisms governing skeletal complications in type 1 diabetes.Structure and organization of odontoblasts.The effect of doxycycline hyclate, chlorhexidine gluconate, and minocycline hydrochloride on osteoblastic proliferation and differentiation in vitro.Osteogenic protein-1 overcomes inhibition of fracture healing in the diabetic rat: a pilot study.Extracellular glucose influences osteoblast differentiation and c-Jun expression.P38 and activating transcription factor-2 involvement in osteoblast osmotic response to elevated extracellular glucose.Dose-response relationships between energy availability and bone turnover in young exercising women.The "cyclic" regimen of low-dose doxycycline for adult periodontitis: a preliminary study.A study of the regional distribution of bone formed around hydroxyapatite implants in the tibiae of streptozotocin-induced diabetic rats using multiple fluorescent labeling and confocal laser scanning microscopy.Live quantitative monitoring of mineral deposition in stem cells using tetracycline hydrochloride.Minocycline impairment of both osteoid tissue removal and osteoclastic resorption in a synchronized model of remodeling in the rat.Uncontrolled diabetes hinders bone formation around titanium implants in rat tibiae. A light and fluorescence microscopy, and image processing study.
P2860
Q34063149-894F7751-0118-4015-9A51-8513A9FC7AE2Q36012130-A6D08E73-20FB-4A67-B659-E9FFE3BA20E0Q36281802-99F25E1B-EDC2-4999-AAFF-B27207912E29Q37858842-D4FDA077-C579-4F9E-B351-E9DB5620541FQ38553514-9D17B610-BA29-41E4-9F9B-40C538F41902Q38939772-1C8D1FA0-4A80-4B70-A21F-61650685BE35Q41081715-23E4847C-3425-42B3-B977-B8A2AE3CA5FBQ41996160-B8B2A165-A872-4685-92DB-C0D3D092B50CQ42028937-A1D55C23-4EBC-4911-A271-AF990A4FD977Q42797874-22AAE420-8E71-4FDB-9558-A2269AD71252Q42811955-84AD28D3-7145-413F-BE8A-327CF029791BQ44961455-F166918F-E44C-49A7-82B0-54BEEF8A97D9Q45098129-29DAAA65-562D-4F1C-9971-DD67DD88142AQ46292142-6EDC013E-1FE7-4EF6-AE11-8399E8615543Q49897371-B89B6E93-A9FB-4EB3-88A5-69E6F1FED417Q50105702-BB49CAC4-BCFF-4D49-B5AD-050F4FAB17A9Q50524435-950A5040-8C8B-4761-85E7-92F90A5562CB
P2860
Tetracycline administration restores osteoblast structure and function during experimental diabetes.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Tetracycline administration re ...... during experimental diabetes.
@en
Tetracycline administration re ...... during experimental diabetes.
@nl
type
label
Tetracycline administration re ...... during experimental diabetes.
@en
Tetracycline administration re ...... during experimental diabetes.
@nl
prefLabel
Tetracycline administration re ...... during experimental diabetes.
@en
Tetracycline administration re ...... during experimental diabetes.
@nl
P2093
P356
P1476
Tetracycline administration re ...... during experimental diabetes.
@en
P2093
P2860
P356
10.1002/AR.1092310105
P577
1991-09-01T00:00:00Z